
Pacific Biosciences of California Investor Relations Material
Latest events

AGM 2025
Pacific Biosciences of California
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pacific Biosciences of California Inc
Access all reports
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.
Key slides for Pacific Biosciences of California Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pacific Biosciences of California Inc


Q1 2025
Pacific Biosciences of California Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PACB
Country
🇺🇸 United States